1.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 1 to under 22 at first relapse
Sponsor: NCI
Protocol IDs: COG-ASCT0431, ASCT0431, COG-PBMTC-ONCO51, NCT00382109
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to 17
Sponsor: NCI
Protocol IDs: DFCI-05001, NCT00400946
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 1 to under 31
Sponsor: NCI
Protocol IDs: COG-AALL0434, AALL0434, NCT00408005
|
|
4.
|
Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 and under at diagnosis
Sponsor: NCI
Protocol IDs: COG-AALL0631, AALL0631, NCT00557193
|
|
5.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 75 and under
Sponsor: NCI, Other
Protocol IDs: CDR0000258507, FHCRC-1655.00, NCT00052520
|
|
6.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 16 to 120
Sponsor: Other
Protocol IDs: 090331, NCT00983528
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 1 to 31
Sponsor: NCI
Protocol IDs: COG-AALL07P1, AALL07P1, NCT00873093
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 8 to 75
Sponsor: NHLBI
Protocol IDs: 090087, 09-H-0087, NCT00859586
|
|
9.
|
Phase: Phase II
Type: Treatment
Status: Active
Age: 12 to 40
Sponsor: Other
Protocol IDs: 2006-0375, NCT00866749
|
|
10.
|
Phase: Phase I
Type: Treatment
Status: Active
Age: 1 to 16
Sponsor: Other
Protocol IDs: 20010133, NCT00460421
|
|
11.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 months to 29 years at relapse
Sponsor: NCI
Protocol IDs: COG-AALL02P2, AALL02P2, NCT00096135
|
|
12.
|
Phase: No phase specified
Type: Treatment
Status: Active
Age: 365 days and under
Sponsor: Other
Protocol IDs: DCOG-INTERFANT-06, DCOG-INTERFANT-06, EUDRACT-2005-004599-19, NCT00550992, CCLG-LK-2006-10
|
